ArticleAlzheimer's & dementia (New York, N. Y.)2022

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M

Pradeep J Nathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.